FACE 12 - Understanding the epidemiology of FASD: The role of meconium testing
This event was held on Tuesday, September 13, 2011 t the Stanhope Beach Resort & Conference Centre, Prince Edward Island, Canada as part of the 12th Annual FACE Research Roundtable. Click here for a list of other session from this conference.
The 12th FACE Research Roundtable was organized by the Motherisk Program and sponsored by the Brewers Association of Canada.
Stuart M. MacLeod, MD, PhD, FRCPC, Vice President, Research, BC Provincial Health Services Authority; Professor, Pediatrics, Faculty of Medicine, University of British Columbia
Dr. MacLeod will present the results of a symposium conducted by the Canadian Association of Pediatric Hospitals and Health Centres (CAPHC) on meconium testing as a population based approach to understanding the incidence of FASD in Canada. The use of meconium testing has been validated at The Hospital for Sick Children and has been tested on a population basis in Grey-Bruce County in Ontario. Following careful review, meconium testing was featured in the CAPHC FASD toolkit released in 2010. A second Canadian population study is presently underway in Prince Edward Island with support from the Public Health Agency of Canada. Bringing the feedback and recommendations that took part in the CAPHC and PHAC pre-conference symposium, Dr. MacLeod will focus on the strengths and limitations of meconium testing as a tool for use in epidemiologic surveillance.
Sponsors
The 12th FACE Research Roundtable was organized by the Motherisk Program and sponsored by the Brewers Association of Canada.
